Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
St. Antonius Hospital |
---|---|
Information provided by: | St. Antonius Hospital |
ClinicalTrials.gov Identifier: | NCT00267800 |
The cause of most interstitial lung diseases (ILDs) is still unknown. Further research, for example to determine predisposing genetic factors, is therefore needed. A database with relevant clinical data and DNA/serum samples of ILD patients could facilitate future research on the cause of ILDs.
Condition |
---|
Interstitial Lung Diseases |
Study Type: | Observational |
Official Title: | Registration of Clinical Data and DNA/Serum of Patients With Interstitial Lung Diseases (ILD) |
Estimated Enrollment: | 100000 |
Study Start Date: | January 2006 |
Protocol title: 'Registration of clinical data and DNA of patients with Interstitial Lung Disease (ILD)' Rationale: The etiopathogenesis of most Interstitial Lung Diseases (ILDs) is still unknown. Further research, e.g. to determine predisposing genetic factors, is therefore needed. A database with relevant clinical data and DNA/serum samples of ILD patients could facilitate future research on the etiopathogenesis of ILDs. Objective: Availability of relevant clinical data and DNA/serum samples of ILD patients in a database. Those data can be used for future research.
Study design: A prospective observational study
Study population: Patients diagnosed with ILD attending the pulmonology department in participating hospitals.
Intervention: a blood sample is taken from each patient. Furthermore, additional information is collected from the medical file.
Main study parameters/endpoints: DNA and serum sample, demographic variables, medical information, occupational history and hobbies.
Nature and extent of the burden and risks associated with participation, group relatedness: two tubes of blood will be drawn from the patients. The risks of drawing blood from a vein are minimal.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Netherlands | |
St. Antonius Hospital | |
Nieuwegein, Netherlands, 3435CM | |
UMC Utrecht | |
Utrecht, Netherlands, 3584 CX | |
Mesos Medisch Centrum | |
Utrecht, Netherlands, 3527 CE | |
Diakonessenhuis | |
Utrecht, Netherlands, 3508 TG |
Principal Investigator: | J.M.M. van den Bosch, M.D. | St. Antonius Hospital |
Principal Investigator: | J.C. Grutters, M.D. | St. Antonius Hospital |
Study ID Numbers: | R05.08/A |
Study First Received: | December 19, 2005 |
Last Updated: | August 7, 2008 |
ClinicalTrials.gov Identifier: | NCT00267800 History of Changes |
Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
Lung disease, Interstitial Sarcoidosis Pulmonary fibrosis |
Lung Diseases, Interstitial Respiratory Tract Diseases Fibrosis |
Lung Diseases Sarcoidosis Pulmonary Fibrosis |
Lung Diseases, Interstitial Respiratory Tract Diseases Lung Diseases |